amylyx glp-1 shores up pipeline with rights to antagonist | Biotechnology Amylyx acquires Eiger's GLP-1 antagonist

If you have been diagnosed with gastroparesis, bowel obstruction, or vision loss after being put on GLP-1 RAs, you might be eligible to file a claim under MDL 3094

Overall Wellness Support: Enhance your overall well-being with our Akkermansia Probiotic, designed to promote a healthier gut, stronger immunity, improved metabolism, and balanced energy levels

Do GLP-1 medications make you tired

PlexusDx explains how dual-action GLP-1 and GIP receptor agonists let you enjoy meals you love while staying on track with your weight loss goals

The association between glucagonlike peptide1 receptor agonists (GLP1 RAs) and depression remains uncertain due to contradictory evidence